Identification and characterization of novel low‐density lipoprotein receptor mutations of familial hypercholesterolaemia patients in Taiwan
Authors:
- 7 November 2006
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 36 (12) , 866-874
Abstract
Familial hypercholesterolaemia (FH) is an autosomal dominant disease associated with a very high risk of coronary vascular disease. The study objective was to identify patients with FH in Taiwan and characterize novel mutations. Fifty-one patients with suspected FH living in Taiwan were screened for mutations in both the low-density lipoprotein (LDL) receptor and the apolipoprotein (apoB) genes using the multiplex polymerase chain reaction and exon-by-exon DNA sequencing technique. Functional consequences on LDL receptor activity were characterized in vitro for novel mutations and family pedigree was also analyzed. Thirteen different functional mutations in the LDL receptor gene and one mutation in the apoB gene were found in 21 patients. Among the 13 mutations in the LDL receptor gene, 10 were single-point missense mutations, one was a two-point mutation in the same allele, one was a non-sense mutation and one was a frame-shift mutation. There were three novel mutations, including two missense mutations (M510K and W512R) and one frame-shift mutation (1953 delTA mutation). The characterization of missense M510K retained 36.2% of the activity of the normal receptor. Conversely, frame-shift 1953 delTA and missense W512R led to defective proteins, with only 0-6% of normal receptor activity. The study identified 13 LDL receptor gene mutations and characterized three novel mutations causing FH in Taiwan. This facilitated a better understanding of FH among the Chinese population and may enable diagnosis of FH at the molecular level at a presymptomatic, early age.Keywords
This publication has 30 references indexed in Scilit:
- Update of the molecular basis of familial hypercholesterolemia in The NetherlandsHuman Mutation, 2005
- FH clinical phenotype in Greek patients with LDL‐R defective vs. negative mutationsEuropean Journal of Clinical Investigation, 2004
- Identification and characterization of LDL receptor gene mutations in hyperlipidemic ChineseJournal of Lipid Research, 2003
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemiaEuropean Journal of Clinical Investigation, 2001
- A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor geneJournal of Human Genetics, 2001
- Low‐density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemiaClinical Genetics, 2000
- Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNACell, 1984
- Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in ManScience, 1974